Although numerous studies have demonstrated that ligand-independent S897 phosphorylation of EphA2 (pS897-EphA2) promotes cancer development and progression4,10–15, the role of ligand-independent Y772 phosphorylation of EphA2 (pY772-EphA2) in cancers is unclear. Here, EPHA2 is linked to cancer.